of HSCs in vivo are quiescent, even though cytokines known to regulate HSCs, such as c-Kit and mpl ligand, are considered to be growth factors that stimulate cell cycle progression. How such factors maintain quiescent HSCs is still a mystery. Presumably, direct interactions of the HSCs with neighboring cells (niche cells); secreted factors such as nutrients, hormones, and metabolites; or oxygen tension modulate the signals of growth factors in the HSCs.In the niche, extrinsic factors coordinate multiple processes that are essential for HSC homeostasis and are mediated by metabolic regulation. Several studies have suggested that HSCs utilize glycolysis, whereas oxidative phosphorylation becomes dominant in progenitors. Like HSCs, LSCs exhibit low levels of ROS; however, unlike HSCs they appear to have low glycolytic flow, indicating that there are critical differences in metabolic regulation between these cell types. In this issue, Jiang et al. argue that knowledge of the molecular mechanisms of metabolic regulation mediated by key molecules, e.g., HIF1/2, AMPK, and mTOR, will provide novel therapeutic approaches for eradiation of LSCs [3].Multistep processes of hematopoiesis and leukemogenesis are controlled by epigenetics, which regulates gene expression by increasing or decreasing DNA methylation or post-translational modifications of histone core proteins. DNA methylation proceeds by the transfer of a methyl group onto the C5 position of the cytosine to form 5-methylcytosine. DNA methylation is catalyzed by a family of DNA methyltransferases (DNMTs). DNA demethylation by DNA hydroxylase TET enzymes is a critical process for reversing this methylation. The article by Celik et al. discusses recent studies showing that the cooperative regulation of these DNA methylation enzymes is critical for hematopoiesis and leukemogenesis [4]. Acetylation, methylation, and phosphorylation of histones change the Hematopoietic stem cells (HSCs) are defined as cells that have the ability to perpetuate undifferentiated status through self-renewal and to develop into mature cells through differentiation. Fine-tuning of self-renewal and differentiation programs, mediated by cooperative networks of intrinsic and extrinsic factors, contributes to stem cell homeostasis in vivo [1,2]. Accumulating evidence has revealed the presence of "stemness" signals; that is, molecules and signaling pathways that play critical roles in maintaining the undifferentiated properties of HSCs. Common mechanisms may regulate stemness in HSCs and leukemias: although leukemia stem cells (LSCs) appear to be heterogeneous, their gene expression profiles closely resemble those of normal HSCs or progenitors. Understanding the commonalities and critical differences between HSCs and LSCs in the regulation of stemness is required to find the therapeutic window. In this issue, four articles review the physiological and pathophysiological roles of metabolism and epigenetic regulation in hematopoiesis. The articles include current basic knowledge and recent topics in...